- HMI-115: Frequently Asked Questions About Hair Loss Treatment HMI-115 is an investigational anti-prolactin-receptor antibody being trialled for androgenetic alopecia. It is not approved anywhere; its hair-loss evidence is a 16-person Phase 1b announced only by press release, plus a completed 192-man Phase 2 in China whose results are not yet published.
- azelaic acid: Does it work for all types of hair loss or just DHT? One small randomised trial (26 women) found 5% azelaic acid comparable to 2% minoxidil for female pattern hair loss, and the anti-DHT rationale rests on laboratory work; for alopecia areata, telogen effluvium and seborrhoeic dermatitis there is no trial evidence for azelaic acid at all.
popular antihistamine showing promise for hair loss as an anti-inflammatory and prostaglandin inhibitor
laser therapy for anti-inflammatory and likely insignificant hair regrowth effects
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth
commercial product with a blend of mostly natural ingredients for hair regrowth